+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Retroperitoneal lymphadenectomy (RPLA) or primary cisplatin (CCDP) - based chemotherapy (CHT) in clinical stage (CS) B1/B2 nonseminomatous testicular tumors (NSTT): long term results of the prospective non-randomized study



Retroperitoneal lymphadenectomy (RPLA) or primary cisplatin (CCDP) - based chemotherapy (CHT) in clinical stage (CS) B1/B2 nonseminomatous testicular tumors (NSTT): long term results of the prospective non-randomized study








Accession: 021687925

Download citation: RISBibTeXText


Related references

Poster Retroperitoneal lymphadenectomy (Rpla) or primary cisplatin (Ccdp) based chemotherapy (Cht) in clinical stage (Cs) B1/B2 nonseminomatous testicular tumors (Nstt): long term results of the prospective non-randomized study. European Journal of Cancer Suppl.s 5(4): 305-306, 2007

Primary chemotherapy for clinical stage II nonseminomatous germ cell testicular tumors: Selection criteria and long-term results. Mayo Clinic Proceedings 70(9): 821-828, 1995

The results of the nerve-sparing retroperitoneal lymphadenectomy to clinical stage I nonseminomatous testicular tumors. Rinsho Hinyokika 53(8): 599-602, 1999

Randomized phase III trial comparing retroperitoneal lymph node dissection with one course of bleomycin and etoposide plus cisplatin chemotherapy in the adjuvant treatment of clinical stage I Nonseminomatous testicular germ cell tumors: AUO trial AH 01/94 by the German Testicular Cancer Study Group. Journal of Clinical Oncology 26(18): 2966-2972, 2008

Oncologic efficacy of 2 cycles cisplatin-based chemotherapy for low volume retroperitoneal stage 2 nonseminomatous germ cell tumours Long term results. European Urology Suppl.s 2(1): 156, 2003

Laparoscopic retroperitoneal lymphadenectomy for clinical stage I nonseminomatous testicular cancer Long-term followup The test of time. Journal of Endourology 12(Suppl. 1): S104, 1998

Nerve sparing retroperitoneal lymphadenectomy in clinical stage I, low stage II and after chemotherapy in stage III nonseminomatous testicular cancer. Progress in Clinical and Biological Research 277: 53-62, 1988

Adjuvant chemotherapy for high-risk clinical stage I nonseminomatous testicular germ cell cancer: long-term results of a prospective trial. Journal of Clinical Oncology 14(2): 441-448, 1996

Long-term results following adjuvant chemotherapy in patients with clinical stage I testicular nonseminomatous malignant germ cell tumors with high risk factors. Journal of Urology 161(4): 1148-1152, 1999

Management of patients with clinical stage I nonseminomatous testicular germ cell tumours: active surveillance versus primary chemotherapy versus nerve sparing retroperitoneal lymphadenectomy. Archivos Espanoles de Urologia 65(2): 215-226, 2012

Long-term followup results of 1 cycle of adjuvant bleomycin, etoposide and cisplatin chemotherapy for high risk clinical stage I nonseminomatous germ cell tumors of the testis. Journal of Urology 179(1): 163-166, 2008

Retroperitoneal lymphadenectomy and aggressive chemotherapy in nonbulky clinical Stage II nonseminomatous germinal testis tumors. Cancer 53(6): 1363-1368, 1984

Thoracic metastectomy for nonseminomatous testicular tumors (Nstt): Long term survival and prognostic factors. European Urology Suppl.s 12(1): e1060-e1061, 2013

2 cycles cisplatin-based chemotherapy for low volume retroperitoneal stage II nonseminamatous germ cell tumors Oncologic efficacy and long term results. Journal of Urology 169(4 Suppl.): 240, 2003

Nonseminomatous Testicular Cancers in Clinical Stage Iia/B: Primary Chemotherapy or Primary Lymphadenectomy?. Oncology Research and Treatment 21(6): 514-516, 1998